CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-17 | Oki Mark K Chief Financial Officer | Purchase | +10,000 | $2.89 | $29K | 10,000 |
| 2025-03-17 | Stewart Richard Alistair Chieve Executive Officer | Purchase | +10,000 | $2.86 | $29K | 60,876 |
| 2024-03-04 | Stewart Richard Alistair Executive Chairman | Purchase | +10,000 | $4.59 | $46K | 38,501 |
| 2024-03-04 | Bencich John CEO | Purchase | +10,000 | $4.59 | $46K | 76,724 |
| 2023-05-30 | Bencich John CEO | Purchase | +5,000 | $5.50 | $28K | 66,730 |
| 2022-11-18 | Bencich John CEO | Purchase | +22,000 | 36,920 | ||
| 2021-05-27 | Bencich John CEO | Purchase | +6,000 | $7.00 | $42K | 6,141 |
| 2019-06-11 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +12,813 | $3.80 | $49K | 1,026,000 |
| 2019-06-11 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 1,026,000 | ||
| 2019-05-23 | Stewart Richard Alistair Chairman & CEO | Purchase | +17,500 | $3.61 | $63K | 212,530 |
| 2012-08-15 | GOLDSTEIN JACK Director | Purchase | +1,000 | $14.38 | $14K | 1,000 |
| 2012-06-01 | MATTINGLY MARTIN A Director | Purchase | +1,000 | $12.46 | $12K | 1,000 |
| 2011-08-09 | PARKER H STEWART Director | Purchase | +3,000 | $10.09 | $30K | 3,000 |
| 2010-11-09 | Lawrence Cameron William Principal Financial Officer | Purchase | +650 | $15.73 | $10K | 3,050 |
Page 1 of 1 · 14 trades